Skip to main content
Justin Long, MD, Neurology, Saint Louis, MO

JustinMatthewLongMDPhD

Neurology • Saint Louis, MO

Neurodegenerative, Dementia & Geriatrics

Assistant Professor at Washington University

Join to view full profile

Dr. Long is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Long's full profile

Already have an account?

  • Office

    4921 Parkview Pl
    # Dv
    Saint Louis, MO 63110
    Phone+1 314-362-1408
    Fax+1 314-286-1985

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Dementia, 2018 - 2020
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2014 - 2018
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 2014
  • Indiana University
    Indiana UniversityPhD, Medical Neuroscience, 2007 - 2013
  • Indiana University
    Indiana UniversityBS, Biology, Highest Academic Distinction, General Honor Notation, 2001 - 2004

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2026
  • MO State Medical License
    MO State Medical License 2017 - 2026
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Journal Articles

  • Novel Upregulation of Amyloid-Β Precursor Protein (APP) by microRNA-346 via Targeting of APP mRNA 5′-Untranslated Region: Implications in Alzheimer’s Disease  
    Justin Long, MD, Nature

Press Mentions

  • COVID-19 Closes Labs, Slows Data Collection—The Impact on the Neurology Research Pipeline
    COVID-19 Closes Labs, Slows Data Collection—The Impact on the Neurology Research PipelineJuly 11th, 2020
  • Aducanumab About-Face: Experts Weigh In
    Aducanumab About-Face: Experts Weigh InJuly 11th, 2020
  • A Discontinued Alzheimer’s Trial Comes Alive Again. Will Biogen’s Aducanumab Survive the FDA Review?
    A Discontinued Alzheimer’s Trial Comes Alive Again. Will Biogen’s Aducanumab Survive the FDA Review?July 11th, 2020

Grant Support

  • The role of 25-hydroxycholesterol in modulating ApoE-dependent Alzheimer disease-related pathogenesisWASHINGTON UNIVERSITY2020–2025

Dr. Justin Long, Dr. Justin Long, MD, Dr. J Long, Dr. Justin Matthew Long